Search…

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    Campaigners Criticize Drug Delays for Rare Disease

    1 week ago

    1

    0

    Patients with Friedreich's Ataxia are expressing frustration over delays in the reimbursement decision for Skyclarys, the only EU-authorized treatment for their condition. The HSE has referred the application for further review, extending the wait for approval. Campaigners argue that the prolonged process is heartbreaking and detrimental to patients' health, as they urgently seek access to this potentially life-changing drug.
    Click here to Read more
    Prev Article
    Bonnie Ryan Returns Home to Ireland
    Next Article
    Jamey Carney Honored at Funeral in Killarney

    Related Health Updates:

    Comments (0)

      Leave a Comment